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Incorporation of other hetero-compounds to parent coumarin increases its effectiveness towards its bioactivity. In view of 
this finding we have synthesized coumarin triazole derivatives. The key synthon used for this reaction pathway are 7-hydroxy-
4-methyl-2H-chromen-2-one. This substituted coumarin has been refluxed with 1-bromo-2-chloroethane in presence of
anhydrous K2CO3 to afford 7-(2-chloroethoxy)-4-methyl-2H-chromen-2-one, which has been condensed with triazole to yield
4-methyl coumarin triazole derivative by optimising solvent/base pair. 4-Methyl group of coumarin triazole derivative has been
condensed with aromatic aldehydes to afford 7-(2-(1H-1,2,4-triazol-1-yl) ethoxy)-4-(styryl/4-substituted styryl)-2H-chromen-2-
one 7a-e. All the synthesized products are characterized using IR and, 1H, 13C NMR, mass spectroscopy and elemental analysis.
Final synthesized compounds 7a-e have been evaluated for their anti-bacterial and anti-fungal activity.
Keywords: Coumarin triazole, anti-bacterial, anti-fungal activities, solvent/base pair 
2H-1-Benzopyran-2-ones as an elite class of naturally 
occurring compounds that possess promising 
therapeutic perspective due to diversity in their 
structural complication. It also belongs to the flavonoid 
class of plants, secondary metabolites, natural and 
synthetic origin, such as substituted coumarins to 
polysubstituted polycyclic/fused coumarins1,2. Warfarin 
is a 4-hydroxy coumarin moiety. Warfarin has been 
isolated from woodruff as well as from lavender and 
used to prevent clotting of blood in the veins, lungs or 
heart3. Hydroxycoumarins are known to be powerful 
chain-breaking anticoagulants and anti-oxidants which 
can prevent free radical injury by scavenging reactive 
oxygen species4. Methylcoumarin derivatives, have 
demonstrated growth-inhibitory activity against two 
human tumour cell lines, breast carcinoma MCF-7 and 
hepatocellular carcinoma HePG-2 5,
6
. Also, it has been
reported as anti-proliferative activity in prostate cancer, 
malignant melanoma and metastatic renal cell 
carcinoma in clinical trials5. 
Some classes of triazole compounds are now 
available in the market or in the final stage of clinical 
trials
7
. Because of broad spectrum of triazole and 
improved safety profile, triazoles play a principal role 
in the treatment of systemic fungal infections. But the 
widespread use of these compounds has led to the 
development of resistance in recent years. As a 
consequence, development of more effective antifungal 
azoles with fewer adverse effects, is a main area of 
antifungal drug research8. 1,2,4-Triazole moieties have 
exhibited antibacterial9, antifungal10, antioxidant11, 
antituberculosis, anti-HIV and antiviral12 activities. 
Substituted coumarins are known to be biologically 
versatile compounds possessing several biological 
properties13,14. It has been reported that coumarin 
compounds bearing other heterocyclic systems possess 
a number of interesting biological activities such as 
anti-tumor5, antimicrobial15 and anticancer16. 
The insertion of other heterocyclic moiety either as 
substituent group or as a fused component into parent 
coumarin modifies the property of parent coumarin 
and converts it into a more useful product17. In light 
of these findings, we efficiently synthesized 
substituted coumarin and successfully introduce 
1,2,4-triazol moiety in coumarin scaffold afford 
coumarin triazole derivatives. The resulting compounds 
have been analysed for their antimicrobial activitiy. 
Results and Discusssion 
Coumarin constitutes one of the major class of 
naturally occurring compounds and attention in its 
chemistry continues unabated because of its usefulness 




in various fields. In view of its valuable biological 
importance and in continuation of our interest in the 
synthesis of heterocyclic compounds, it was aimed to 
synthesize some coumarin containing 1,2,4-triazole 
moiety and evaluate their antimicrobial activity. 
The precursor compound 1 was prepared from 
resorcinol and ethyl acetoacetate in presence of 
iodine18.The structure of compound 1 was confirmed 
by spectral analysis. FTIR spectra recorded broad 
peak at 2951-3500 cm-1 due to -OH stretching 
frequency and peak at 1681 cm-1 indicates C=O group 
of coumarin. This data is also supported by 1H NMR 
spectra, one proton shows singlet at δ 10.31 ppm 
indicating presence of -OH group. Substituted 
coumarin 1 on condensation with 1-bromo-2-chloro 
ethane in acetonitrile in presence of anhydrous K2CO3 
affords compound 3 in good yield. In 1H NMR spectra 
of 3, two protons shows triplets at δ 3.84 and 4.28 
ppm indicating presence of –CH2Cl and –CH2O-
groups respectively. Compound 3 shows absence of –
OH peak, indicating substitution of ethane chloride at 
that position. 
For the preparation of coumarin triazole derivative 5, 
we used initially K2CO3/acetonitrile pair for 
condensation of triazole 4 with 4-methylcoumarin 
derivative 3 to afford a very low yield product 
(Table I, entry 1). Therefore, we optimized this step 
with different solvents and bases (Table I). In next 
attempt we used ethanol/KOH pair and reflux for 26 h 
but coumarin remains as unreacted, product was not 
formed (Table I, entry 2). Very poor yields were 
obtained in acetone/ K2CO3 and acetone/KOH, with 
extended reaction time (Table I, entries 3, 4). So, we 
turned towards the system dichloromethane/KOH and 
surprisingly, we got product within 4 h with shiny 
appearances. It revealed that dichloromethane/KOH 
was the most regimented solvent/base pair for the 
formation of coumarin triazole 5 (Scheme I). 
Formation of compound 5 is fully supported by  
1H NMR spectra, one proton shows singlet at δ 7.91 
and 8.49 ppm indicates two protons of triazole ring. 
Three protons shows singlet at δ 2.39 ppm indicating 
methyl group of coumarin. 13C NMR also shows peak 
at δ 144.3 and 152.5 ppm indicating two carbons of 
triazole ring. The 4-methyl group of compound 5 
undergo condensation with aromatic aldehydes in 
presence of piperidine at 120°C to afford 7-(2-(1H-
1,2,4-triazol-1-yl)ethoxy)-4-(4-substitutedstyryl)-2H-
chromen-2-one 7a-e (Scheme I). 1H NMR spectra of 
coumarin triazole derivative 7a-e shows 
disappearances of peak at δ 2.39 ppm indicating 
condensation of –CH3 group with aromatic aldehydes. 
 
 
Scheme I — Synthesis of 7-(2-(1H-1,2,4-triazol-1-yl)ethoxy)-4-(4-substitutedstyryl)-2H-chromen-2-one 7a-e 
Table I — Optimization of solvents and basic condition for 
formation of compounda 5 
Entry Solvent Base Time (h) Yieldb (%) 
1 Acetonitrile K2CO3 28 40 
2 Ethanol KOH 26 − 
3 Acetone K2CO3 30 21 
4 Acetone KOH 31 32 
5 dichloromethane KOH 04 78 
a Reaction conditions: (3 mmol) compound 3, (6 mmol) triazole 4, 
(6 mmol) base and (3 mL) solvent, b Isolated Yield. 




All the synthesized compounds have been thoroughly 
characterized by IR, 1H and 13C NMR, mass 
spectroscopy, elemental analysis and screened for 
their antimicrobial activities. 
 
Antimicrobial Activity 
Antimicrobial activity was evaluated by well 
diffusion method19. All the compounds were screened 
for their antibacterial activity against E. coli, 
S. aureus, P. aeruginosa and S. typhi and antifungal 
activity against C. albicans and A. flavus, using 
Streptomycin and Greseofulvin as the reference drug 
respectively. All these compounds showed about 44-
51% inhibition against Escherichia coli and 
Staphylococcus aureus while they did not exhibit any 
activity against Salmonella typhi (Table II). Only 
three compounds are active against Pseudomonas 
aeruginosa (44-52%). Antifungal data revels that 
compounds 7c and 7d demonstrated the broadest 
spectrum of inhibitory activity (74.07% and 66.66% 
respectively) against Aspergillus flavus. Compound 
7c, 7d and 7e are inactive against Candida albicans 
while compound 7a and 7b were also inactive against 
Aspergillus flavus, other compounds show 40-44% 
activity compared to standard drug Greseofulvin. 
Zone of inhibition of antibacterial and antifungal 
activity is shown in Figure 1. 
 
Materials and Methods 
Melting points was measured in open capillaries 
and are uncorrected. Progress of reaction was 
monitored by silica gel-G coated TLC plates in n-
hexane: ethyl acetate system (1:1). The spot was 
visualized by exposing dry plate in UV chamber. IR 
spectra were recorded on Schimadzu IR affinity 
model-1 spectrometer using KBr. 1H and 13C NMR 
spectra were recorded on a Bruker AVANCE II 400 
NMR spectrometer at frequencies 400 MHz and 100 
MHz respectively (SAIF, Panjab University 
Chandigarh). CDCl3/DMSO-d6 was used as solvents 
and TMS as internal standard. Mass spectra were 
recorded on WATERS Q-TOF MICROMASS (ESI-
MS) (SAIF/CIL, Panjab University, Chandigarh). 
Elemental analysis was done from ThermoFinnigan, 
CHNS analyser (SAIF, Panjab University Chandigarh). 
 
Experimental Section 
Procedure for the preparation of 7-(2-
chloroethoxy)-4-methyl-2H-chromen-2-one, 3 
To a stirred solution of 7-hydroxy-4-methyl 
coumarin (17mmol) and potassium carbonate 
(10mmol) in 30 mL of acetonitrile, 1-bromo-2-chloro 
ethane (17mmol) was added and refluxed for 25 h 
(monitored by TLC). After removal of solvent, the 
content was extracted with dichloromethane (30 mL), 
washed with10% potassium hydroxide solution (2×20 
mL) and dried over magnesium sulphate. The solvent 
was evaporated under reduced pressure and 
recrystallized with methanol to yieldcompound 3. 
 
7-(2-Chloroethoxy)-4-methyl-2H-chromen-2-one, 
3: White solid, m.p. 168-169°C; Yield 75%; IR 
(KBr): 854 (C-Cl), 1610 (C=C), 1720 (C=O), 2958  
(-CH aliphatic), 3074 (-CH aromatic) cm-1;1H NMR 
(400 MHz, CDCl3): δ 2.40 (s, 3H, -CH3), 3.84 (t, 2H, 
J=5.6Hz, -CH2-Cl), 4.28 (t, 2H, J=5.7Hz, -CH2-O), 
6.14 (s, 1H), 6.80 (d, 1H, J=2.3Hz), 6.88 (dd, 1H), 
7.50 (d, 1H, J=8.8Hz); 13C NMR (100 MHz, CDCl3): 
δ 18.6, 41.6, 68.3, 101.6, 112.2, 112.4, 114.0, 125.7, 
152.4, 155.1, 161.0; MS: m/z[M+H]+ : 239. 
 
Procedure for the preparation of 7-(2-(1H-1,2,4-
triazol-1-yl)ethoxy)-4-methyl-2H-chromen-2-one, 5 
A mixture of 7-(2-chloroethoxy)-4-methyl-2H-
chromen-2-one 3(12 mmol), triazole4(25 mmol) in 
dichloromethane (30 mL) and KOH (25 mmol) was 
taken in round bottom flask. The reaction mixture was 
refluxed for 4 hr. The progress of reaction was 
monitored by TLC. The cooled reaction mixture was 
then poured into ice-cold water with stirring. The 
Table II — Results of in vitro antimicrobial activity of compounds 7a-e 
 Percent inhibition (Zone of inhibition in mm) 
 Antibacterial activity Antifungal activity 
Entry E. coli S.aureus P.aeruginosa S. typhi C.albicans A.flavus 
7a 57.69 (15) 51.85.(14) 48.00 (12) − 44.00 (11) − 
7b 53.84 (14) 40.74 (11) − − 32.00 (08) − 
7c 53.84 (14) 51.85 (14) 44.00 (11) − − 74.07 (20) 
7d 38.46 (10) 44.44 (12) − − − 66.66 (18) 
7e 46.15 (12) 44.44 (12) 52.00 (13) − − 44.44 (12) 
Strepto-mycin 100 (26) 100 (27) 100 (25) 100 (25) − − 
Greseo-fulvin − − − − 100 (25) 100 (27) 
 




solid was filtered, washed with water several 
times(check by litmus) and recrystallized from MeOH 
to yield compound 5. 
 
7-(2-(1H-1,2,4-Triazol-1-yl)ethoxy)-4-methyl-2H- 
chromen-2-one, 5: White solid, m.p. 160-162°C; 
Yield 78%; IR (KBr): 1512 (C=C), 1614 (C=N),  
1710 (C=O) cm-1; 1H NMR (400 MHz, DMSO-d6):  
δ 2.39 (s, 3H,-CH3), 4.45 (t, 2H, -CH2-Cl), 4.62  
(t, 2H, -CH2-O), 6.13 (s, 1H), 6.87 (d, 2H), 7.58  
(d, 1H), 7.91 (s, 1H), 8.49 (s, 1H); 13C NMR  
(100 MHz, CDCl3): δ 18.1, 48.1, 66.0, 101.2, 111.4, 
 
 
Figure 1 — Antimicrobial activity of compounds 7a-eagainst selected micro-organisms 
 




112.0, 113.4, 125.9, 144.3, 152.5, 154.5, 159.9, 160.6; 
MS: m/z[M+H]+ : 272. 
 
General procedure for the preparation of 7-(2-(1H-
1,2,4-triazol-1-yl)ethoxy)-4-(4-substitutedstyryl)-2H-
chromen-2-one, 7a-e 
To a mixture of 7-(2-(1H-1,2,4-triazol-1-yl) 
ethoxy)-4-methyl-2H-chromen-2-one 5 (1.2 mmol), 
aromatic aldehyde (1.2 mmol),2-3 drops of piperidine 
was added and fused at 120°C for 2 h. After 
completion of reaction, add 10 mL cold water, stir 
well and poured over crushed ice. The precipitate was 
separated by filtration, washed with water and 
purified by recrystallization with methanol to obtain 
the final product 7a-e. 
 
7-(2-(1H-1,2,4-Triazol-1-yl)ethoxy)-4-styryl-2H-
chromen-2-one, 7a: Yellow solid, m.p. 156-157°C; 
Yield 61%; IR (KBr): 1506 (C=C), 1616 (C=N), 1710 
(C=O) cm-1;1H NMR (400 MHz, DMSO-d6): δ 4.45 
(t, 2H), 4.63 (t, 2H), 6.14 (s, 1H), 6.80 (d, 4H), 6.88 
(m, 4H), 7.50 (d, 2H), 7.90 (s, 1H), 8.45 (s, 1H) ; 13C 
NMR (100 MHz, CDCl3): δ 51.1, 70.6, 103.2, 111.5, 
112.5, 118.8, 125.0, 125.9, 128.6, 128.9, 135.4, 143.0, 
150.5, 151.5, 154.6, 159.8 ; MS: m/z[M+H]+ : 360. 
Anal.calcd for C21H17N3O3: C, 70.15; H, 4.43; N, 
11.70. Found: C, 69.84; H, 4.24; N, 11.46%. 
 
7-(2-(1H-1,2,4-Triazol-1-yl)ethoxy)-4-(4-
methoxystyryl)-2H-chromen-2-one, 7b: Dark 
yellow solid, m.p. 186-188°C; Yield 71%; IR (KBr): 
1520 (C=C), 1614 (C=N), 1714 (C=O) cm-1;1H NMR 
(400 MHz, DMSO-d6): δ 4.33 (t, 2H), 4.59 (t, 2H), 
6.11 (s, 1H), 6.70 (d, 2H), 6.86 (d, 4H), 7.02 (dd, 2H), 
7.55 (d, 4H), 7.81 (s, 1H), 8.51 (s, 1H); 13C NMR (100 
MHz, CDCl3): δ 49.3, 54.6, 69.8, 111.5, 105.4, 
105.8,114.5, 118.1, 125.7, 127.5, 130.5, 130.8, 131.3, 
143.5, 150.1, 151.7, 157.3, 157.7; MS: m/z[M+H]+ : 
390. Anal.calcd for C22H19N3O4: C, 67.87; H, 4.92; N, 
10.80. Found: C, 67.64; H, 4.57; N, 10.69%. 
 
7-(2-(1H-1,2,4-Triazol-1-yl)ethoxy)-4-(4-
fluorostyryl)-2H-chromen-2-one, 7c: Red solid, 
m.p. 147-149°C; Yield 69%; IR (KBr): 1516 (C=C), 
1608 (C=N), 1710 (C=O) cm-1;1H NMR (400 MHz, 
CDCl3): δ 4.39 (t, 2H), 4.60 (t, 2H), 6.15 (s, 1H), 
6.77-6.81 (m, 2H), 6.88 (d, 3H), 7.47 (d, 1H), 7.71 (d, 
3H), 7.97 (s, 1H), 8.22 (s, 1H);
 13
C NMR (100 MHz, 
CDCl3): δ 51.3, 68.4, 104.5, 111.3, 116.3,118.2, 
125.6, 130.5, 130.9, 131.6, 143.6, 150.2, 151.3, 159.2, 
159.8 ; MS: m/z[M+H]+ : 378. Anal.calcd for 
C21H16N3O3F: C, 66.85; H, 4.29; N, 11.15. Found: C, 
66.92; H, 3.89; N, 11.24%. 
 
7-(2-(1H-1,2,4-Triazol-1-yl)ethoxy)-4-(4-
chlorostyryl)-2H-chromen-2-one, 7d: Yellow solid, 
m.p. 128-131°C; Yield 59%; IR (KBr): 1519 (C=C), 
1611 (C=N), 1717 (C=O) cm-1;1H NMR (400 MHz, 
DMSO-d6): δ 4.48 (t, 2H), 4.58 (t, 2H), 6.18 (s, 1H), 
6.88-6.94 (m, 4H), 7.25-7.45 (m, 3H), 7.61 (d, 2H), 
7.94 (s, 1H), 8.53 (s, 1H); 13C NMR (100 MHz, 
CDCl3): δ 49.9, 70.7, 111.0, 104.8, 119.7, 127.6, 
125.8, 129.1, 130.5, 131.3, 133.1, 133.8, 143.4, 149.7, 
150.4, 158.5 ; MS: m/z[M]+393, [M+2H]+ 395. 
Anal.calcd for C21H16N3O3Cl: C, 64.06; H, 4.09; N, 
10.65. Found: C, 63.91; H, 3.83; N, 10.24%. 
 
7-(2-(1H-1,2,4-Triazol-1-yl)ethoxy)-4-(4-
nitrostyryl)-2H-chromen-2-one, 7e: Dark yellow 
solid, m.p. 148-150°C; Yield 69%; IR (KBr): 1554 
(C=C), 1614 (C=N), 1710 (C=O) cm-1;1H NMR  
(400 MHz, DMSO-d6): δ 4.45 (t, 2H), 4.63 (t, 2H), 
6.12 (s, 1H), 6.86-6.89 (m, 4H), 7.57-7.59 (m, 4H), 
7.90 (s, 1H), 8.47 (s, 1H); 13C NMR (100 MHz, 
CDCl3): δ 50.1, 69.7, 111.2, 104.2, 118.6, 123.5, 
125.6, 129.1, 130.8, 131.7, 141.3, 142.7, 147.3, 150.8, 
151.8, 158.7, 159.2; MS: m/z[M+H]+405. Anal.calcd 
for C21H16N4O5: C, 62.37; H, 3.99; N, 13.84. Found: 
C, 62.41; H, 3.54; N, 13.54%. 
 
Antimicrobial Assay 
Antimicrobial activity evaluated by agar well 
diffusion method19. Initially agar medium and petri 
plates are sterilised in autoclave. Hot 12-15 mL of 
Muller Hinton agar medium was poured into 
previously sterilized and labelled petri plates. After 
diffusion these petri plates were swabbed with 100µL 
inocula of each test bacterium. Using sterile cork 
borer of 6 mm diameter, wells were bored into seeded 
agar plates and these were loaded with a 100µL 
volume with concentration of 100µg/mL of each 
compound constituted in dimethylsulphoxide (DMSO). 
The plates were incubated for 24 h at 37°C under 
aerobic conditions. After incubation, confluent 
bacterial growth was observed. 
For antifungal activity evaluation Potato dextrose 
agar (PDA) medium was prepared. Apply same 
procedure and concentration as mention above and 
plates were incubated at room temperature for 48 h. 
After incubation, confluent fungal growth was observed 
and measured in mm. All the final compounds were 
tested and diameter of zone of inhibition was compared 
against the zone shown by standard drug Greseofulvin. 





Plentiful source of potential drugs candidate in 
relation to its safety and efficacy is coumarin and 
coumarin related compounds. Coumarin and triazole 
both having biological activity in order to explore 
their activities, we have combined coumarin and 
triazole moiety together, by optimising solvent as well 
as basic condition. Condensation of methyl group  
of coumarin triazole derivatives with aromatic 
aldehydes yield final products 7a-e in good to 
moderate yield. Anti-bacterial properties of the 
synthesized compounds have showed near about  
50% inhibition against selected bacterial culture as 
compared to Streptomycin. Halogen substitution at 
fourth position show remarkable antifungal activity. 
The compounds 7c having 4-flurophenyl and 7d 
having 4-chlorophenyl substituent have been 
exhibited noticeable activity (74.07% and 66.66% 
respectively) towards Aspergillus flavus. 
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